{
  "authors": [
    {
      "author": "Abdoreza Naser Moghadasi"
    },
    {
      "author": "Maryam Poursadeghfard"
    },
    {
      "author": "Tayebeh Kazemi"
    },
    {
      "author": "Samaneh Hosseini"
    }
  ],
  "doi": "10.22038/ijorl.2020.40858.2334",
  "publication_date": "2020-08-28",
  "id": "EN110667",
  "url": "https://pubmed.ncbi.nlm.nih.gov/32850514",
  "source": "Iranian journal of otorhinolaryngology",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "Here, we introduce a young girl, a known case of MS, who developed reversible isolated unilateral sensory-neural hearing loss along imaging activity two weeks after stopping fingolimod. The patient responded well to the intravenous corticosteroid therapy which is the first line treatment of new MS attack."
}